An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells

Experimental and Clinical Immunogenetics

Volumn 13, Issue 1, 1996, Pages 30-35

  Regner, Matthias ^a   Claësson, Mogens H ^a   Bregenholt, Søren ^a   Röpke, Mads ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

MHC class I; Peptides; T2 cells

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN P53;

ANTIGEN BINDING; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; TEMPERATURE SENSITIVITY;

AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; HLA-A2 ANTIGEN; HUMANS; IMMUNOASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX; ORTHOMYXOVIRIDAE; PEPTIDES; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 0030054599     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Salter RD, Cresswell P: Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986;5:943-949.
2. Alexander J, Payne JA, Shigekawa B, Frelinger JA, Cresswell P: The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains. Immunogenetics 1990;31:169-178.
3. Townsend A, Elliott T, Cerundolo V, Foster L, Barber B, Tse A: Assembly of MHC class I molecules analysed in vitro. Cell 1990;62:285-289.
4. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Apella E, Hunt DF, Engelthard VH: HLA-A2.1 associated peptides from a mutant cell line. A second pathway of antigen presentation. Science 1992; 255:1264-1266.
5. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:443-448.
6. Elliott T, Cerundolo V, Elvin J, Townsend A: Peptide-induced conformational change of the class I heavy chain. Nature 1991;351:402-405.
7. Baas EJ, van Santen HM, Kleijmeer MJ, Geuze HJ, Peters PJ, Ploegh HL: Peptide-induced stabilization and intracellular Localization of empty HLA class I complexes. J Exp Med 1992;176:147-156.
8. Stuber G, Modrow S, Hoglund P, Franksson L, Elvin J, Wolf H, Karre K, Klein G: Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur J Immunol 1992; 22:2697-2703.
9. Nijman HW, Houbiers JGA, van der Burg SH, Vierboom MPM, Kenemans P, Kast WM, Metlief CJM: Characterization of cytotoxic T lymphocyte epitopes of a self-protein, p53, and a non-self-protein, influenza matrix: Relationship between major histocompatibility complex peptide binding affinity and immune responsiveness to peptides. J Immunother 1993;14:121-126.
10. Nijman HW, Houbiers JGA, Vierboom MPM, van der Burg SH, Drijfhout JW, D'Amaro J, Kenemans P, Melief CJM, Kast WM: Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur J Immunol 1993;23:1215.
11. Kast WM, Brandt RMP, Drijfhout JW, Melief CJM: Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillovirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J Immunother 1993;14:115.
12. Stuber G, Leder GH, Storkus WJ, Lotze MT, Modrow S, Szekely L, Wolf H, Klein E, Karre K, Klein G: Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur J Immunol 1994;24:765-768.
13. Nijman HW, van der Brug SH, Vierboom MPM, Houbiers JGA, Kast WM, Melief CJM: p53, a potential target for tumor-directed T cells. Immunol Lett 1994;40:171-178.
14. Zeh HJ III, Leder JGH, Lotze MT, Salter RD, Tector M, Stuber G, Modrow S, Storkus WJ: Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum Immunol 1994;39:79-86.
15. Röpke M, Regner M, Claesson MH: T cell-mediated cytotoxicity against p53 derived peptides in bulk and limiting dilution cultures of healthy donors. Scand J Immunol 1995;42: 98-103.
16. Fahnestock ML, Tamir I, Narhi L, Bjorkman PJ: Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 1992;258: 1658-1662.
17. Fahnestock ML, Johnson JL, Feldman RMR, Tsomides TJ, Mauer J, Narhi L, Bjorkman PJ: Effects of peptide length and composition on binding to an empty class MHC heterodimer. Biochemistry 1994;33: 8149-8158.
18. Bouvier M, Wiley DC: Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 1994;265:398-402.
19. Falk M, Rötzschke O, Stefanovic S, Jung G, Rammensee HG: Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 1991;351: 290-296.
20. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A: Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993;74:929-937.